Gauging the treatment gap in dyslipidemia: Findings from the 1999-2000 National Health and Nutrition Examination Survey

Despite advances in dyslipidemia therapy and changes in guidelines over the last decade, LDL-C continues to be inadequately managed among US adults. Of particular concern is the undertreatment of high-risk patients and failure of many treated patients to achieve LDL-C goal.